Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. The gene discussed is NR3C1; the disease is Cushing syndrome due to macronodular adrenal hyperplasia.